Association of the American Heart Association’s new “Life’s Essential 8” with all-cause and cardiovascular disease-specific mortality: prospective cohort study

dc.contributor.authorSun Jiahong
dc.contributor.authorLi Yanzhi
dc.contributor.authorZhao Min
dc.contributor.authorYu Xiao
dc.contributor.authorZhang Cheng
dc.contributor.authorMagnussen Costan G.
dc.contributor.authorXi Bo
dc.contributor.organizationfi=sydäntutkimuskeskus|en=Cardiovascular Medicine (CAPC)|
dc.contributor.organizationfi=tyks, vsshp|en=tyks, varha|
dc.contributor.organizationfi=väestötutkimuskeskus|en=Centre for Population Health Research (POP Centre)|
dc.contributor.organization-code1.2.246.10.2458963.20.35734063924
dc.contributor.organization-code1.2.246.10.2458963.20.42471027641
dc.converis.publication-id179308774
dc.converis.urlhttps://research.utu.fi/converis/portal/Publication/179308774
dc.date.accessioned2023-04-27T02:34:49Z
dc.date.available2023-04-27T02:34:49Z
dc.description.abstract<p><b>Background </b>The American Heart Association recently updated its construct of what constitutes cardiovascular health (CVH), called Life’s Essential 8. We examined the association of total and individual CVH metrics according to Life’s Essential 8 with all-cause and cardiovascular disease (CVD)-specific mortality later in  life.<br><b>Methods </b>Data were from the National Health and Nutrition Examination Survey (NHANES) 2005–2018 at baseline linked to the 2019 National Death Index records. Total and individual CVH metric scores including diet, physical activity, nicotine exposure, sleep health, body mass index, blood lipids, blood glucose, and blood pressure were classified as 0–49 (low level), 50–74 (intermediate level), and 75–100 (high level) points. The total CVH metric score (the average of the 8 metrics) as a continuous variable was also used for dose–response analysis. The main outcomes included all-cause and CVD-specific mortality.<br><b>Results </b>A total of 19,951 US adults aged 30–79 years were included in this study. Only 19.5% of adults achieved a high total CVH score, whereas 24.1% had a low score. During a median follow-up of 7.6 years, compared with adults with a low total CVH score, those with an intermediate or high total CVH score had 40% (adjusted hazard ratio [HR] 0.60, 95% confidence interval [CI] 0.51–0.71) and 58% (adjusted HR 0.42, 95% CI 0.32–0.56) reduced risk of all-cause mortality. The corresponding adjusted HRs (95%CIs) were 0.62 (0.46–0.83) and 0.36 (0.21–0.59) for CVD-specific mortality. The population-attributable fractions for high (score ≥ 75 points) vs. low or intermediate (score < 75 points) CVH scores were 33.4% for all-cause mortality and 42.9% for CVD-specific mortality. Among all 8 individual CVH metrics, physical activity, nicotine exposure, and diet accounted for a large proportion of the population-attributable risks for all-cause mortality, whereas physical activity, blood pressure, and blood glucose accounted for a large proportion of CVD-specific mortality. There were approximately linear dose–response associations of total CVH score (as a continuous variable) with all-cause and CVD-specific mortality.<br><b>Conclusions </b>Achieving a higher CVH score according to the new Life’s Essential 8 was associated with a reduced risk of all-cause and CVD-specific mortality. Public health and healthcare efforts targeting the promotion of higher CVH scores could provide considerable benefits to reduce the mortality burden later in life.<br></p>
dc.identifier.eissn1741-7015
dc.identifier.jour-issn1741-7015
dc.identifier.olddbid191423
dc.identifier.oldhandle10024/174510
dc.identifier.urihttps://www.utupub.fi/handle/11111/30264
dc.identifier.urlhttps://doi.org/10.1186/s12916-023-02824-8
dc.identifier.urnURN:NBN:fi-fe2023042538609
dc.language.isoen
dc.okm.affiliatedauthorMagnussen, Costan
dc.okm.affiliatedauthorDataimport, tyks, vsshp
dc.okm.discipline3121 Internal medicineen_GB
dc.okm.discipline3121 Sisätauditfi_FI
dc.okm.internationalcopublicationinternational co-publication
dc.okm.internationalityInternational publication
dc.okm.typeA1 ScientificArticle
dc.publisherBioMed Central Ltd
dc.publisher.countryUnited Kingdomen_GB
dc.publisher.countryBritanniafi_FI
dc.publisher.country-codeGB
dc.relation.articlenumber116
dc.relation.doi10.1186/s12916-023-02824-8
dc.relation.ispartofjournalBMC Medicine
dc.relation.issue1
dc.relation.volume21
dc.source.identifierhttps://www.utupub.fi/handle/10024/174510
dc.titleAssociation of the American Heart Association’s new “Life’s Essential 8” with all-cause and cardiovascular disease-specific mortality: prospective cohort study
dc.year.issued2023

Tiedostot

Näytetään 1 - 1 / 1
Ladataan...
Name:
s12916-023-02824-8.pdf
Size:
1.35 MB
Format:
Adobe Portable Document Format